1.AbbVie Announces ABBV-951(Foslevodopa/Foscarbidopa)Showed Improvement in Controlling Motor Fluctuations Compared to Oral Levodopa/Carbidopa Medication in Pivotal Phase 3 Trial in Patients with Advanced Parkinson's Disease. 2.Patel T, Chang F. Parkinson’s disease guidelines for pharmacists[J]. Cana...
参考资料: [1] AbbVie Advances Upadacitinib (RINVOQ®) to Phase 3 Clinical Trials in Systemic Lupus Erythematosus. Retrieved March 24, 2023 from网页链接 @药明康德内容团队报道 版权说明:本文由药明康德
A Phase 2, Open-Label, Randomized, Global Study of Two Telisotuzumab Vedotin Regimens in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer Cancer is a condition where cells in a specific part of body grow a...
Clinical Program Development- Clinical Program Development works cross-functionally to execute Phase 1-4 clinical research studies. Execution of clinical study protocols and process improvements within an assigned core Therapeutic Area (Oncology, Immunology, Neuroscience, General Medicine). ...
Your participation in trials matters Your participation may help us determine the safety, tolerability, and dosage levels of investigational products and how the body absorbs and processes the investigational products. Potentially learn about your health Although not intended to improve your health, the...
The positive Phase 3 results from the MIRASOL confirmatory trial will support a Marketing Authorization Application (MAA) to the European Union and a supplemental Biologic License Application (sBLA) submission to the U.S. FDA in order to gain full approval. Ongoing clinical devel...
Phase III Non-ulcer dyspepsia Discontinued Diabetic gastroparesis; Postoperative ileus Most Recent Events 28 Feb 2024 Phase-III clinical trials in Non-ulcer dyspepsia in Armenia, Malaysia (PO, Controlled release) (NCT06217393) 19 Jan 2024 Abbott plans a phase III trial for functional dyspepsia...
Latiglutenase was the subject of Phase I and Phase II clinical trials, where according to ImmunogenX it emerged as the only celiac disease treatment that demonstrated histologic success as well as symptomatic improvements in clinical trials. The deal follows the apparent end of a collaboration ...
s pipeline compounds, including commercial products such as Vikera Pak, Mavyret and Imbruvica. He has also led process development of several candidates in Phase 1 to 3 clinical trials. He currently heads the discovery and development of organometallic, bio-catalytic and high-pressure catalytic ...
-Additional presentations includeefficacy and safety data evaluating clinical, endoscopic, and histologic outcomes from both the INSPIRE Phase 3 induction study and the COMMAND Phase 3 maintenance study of risankizumab as a thera...